Stopping Ozempic Raises Cardiovascular Risk by 22 Percent
A VA study of 600,000 patients found that quitting GLP-1 drugs for two years erased all cardiovascular benefits and then some.
Life
The Catholic Convert Surge Built on X Continued into Sunday Services
Record RCIA numbers across U.S. dioceses — 8,598 in Los Angeles alone — confirm that what X's Catholic influencers have been tracking all Lent is real.
Ozempic Is Changing What America Eats and Restaurants Are Adjusting
GLP-1 users consume 21 percent fewer calories and spend a third less on groceries — and Olive Garden just redesigned its menu around them.
Global Heating May Drive Half a Million Extra Premature Deaths by 2050
A Lancet study projects that rising temperatures will make people too hot to exercise, contributing to 520,000 additional premature deaths annually by 2050.
GLP-1 Drugs Are a Social Transformation Not Just a Medical One
One in seven American adults now takes or has taken a GLP-1 drug — and the behavioral, social, and identity shifts are outrunning the clinical data.